Selection and identification of an ssDNA aptamer to NB4 cell
Open Access
- 1 February 2021
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (4) , e23718
Abstract
This study was to find the aptamers with high affinity and specificity binding to acute promyelocytic leukemia (APL) NB4 cell line.These aptamers targeted NB4 cells were selected from a random single‐stranded DNA (ssDNA) library of systematic evolution of ligands by exponential enrichment (CELL‐SELEX). The binding rate of FITC‐ssDNA library and NB4 cells was monitored using flow cytometry and fluorescence microscope. After cloned and sequenced, the structure, specificity, and affinity of these candidate aptamers were further analyzed.After a total of 19 rounds of selection, the ssDNA library was enriched and the BR (19.9%) of the 16th round was 12 times of the first round (1.6%). Three enriched aptamers were obtained from 21 positive clones of the 16th round, and the predicted secondary structures of these aptamers were mainly stem‐loop. The aptamer CX9 had the highest affinity, and the equilibrium dissociation constant (Kd) was 16.2 nM. The fluorescence intensity of CX9 binding to NB4 cells was stronger than HL60 and K562 cells under fluorescence microscopy.The study indicates that aptamer CX9 exhibits high affinity and specificity with NB4 cells and lay a foundation for the rapid diagnostic method to detect APL with fluorescence‐labeled aptamer.Keywords
This publication has 17 references indexed in Scilit:
- Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticlesBiomedicine & Pharmacotherapy, 2020
- Single-Strand DNA-Like Oligonucleotide Aptamer Against Proprotein Convertase Subtilisin/Kexin 9 Using CE-SELEX: PCSK9 Targeting SelectionCardiovascular Drugs and Therapy, 2020
- Acute promyelocytic leukemia (APL): remaining challenges towards a cure for allLeukemia & Lymphoma, 2019
- Advances in aptamer screening technologiesTalanta, 2019
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaNew England Journal of Medicine, 2013
- Curative Strategies in Acute Promyelocytic LeukemiaHematology-American Society Hematology Education Program, 2008
- Acute promyelocytic leukemia: evolving therapeutic strategiesBlood, 2002
- Oligonucleotide aptamers that recognize small moleculesCurrent Opinion in Structural Biology, 1999
- Nucleic Acid Selection and the Challenge of Combinatorial ChemistryChemical Reviews, 1997
- The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cellsCell, 1993